Evofem Biosciences Inc. (EVFM)

Trade EVFM now with
8/4/2020 8:11:15 AM Evofem Q2 Loss Attributable To Stockholders $52.7 Mln Or $0.91/Shr Vs Loss Of $35.5 Mln Or $0.97/Shr Last Year
7/1/2020 8:21:05 AM Evofem Biosciences Issues Letter To Stockholders; Says Commercial Launch Of Phexxi Is On-Track For September
6/2/2020 11:29:53 PM Evofem Announces Pricing Of 28.5 Mln Shares At $3.50/Shr
6/2/2020 4:02:18 PM Evofem Announces Proposed Public Offering Of Common Stock
5/21/2020 4:06:18 PM PDL BioPharma Completes Distribution Of Evofem Biosciences Common Stock To PDL Stockholders
5/6/2020 8:08:36 AM Evofem Biosciences Q1 Net Loss $19.1 Mln Or $0.40/Shr Vs Loss Of $18.1 Mln Or $0.67/Shr Last Year
4/24/2020 8:35:26 AM Evofem Biosciences Says Three New Phexxi Data Sets Accepted For Presentation At ACOG Annual Meeting
3/12/2020 8:11:41 AM Evofem Biosciences Q4 Loss Attributable To Holders $12.7 Mln Or $0.27/Shr Vs Loss $15.0 Mln Or $0.58/Shr Last Year
2/26/2020 8:31:58 AM Evofem Biosciences Appoints Former FDA Division Director Lisa Rarick To Board
12/18/2019 7:32:52 AM FDA Acknowledges Receipt Of Evofem' NDA Resubmission For Amphora For Prevention Of Pregnancy